June 23, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: | Titan Medical Inc. Registration Statement on Form F-1 (File No. 333-238830) |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced registration statement be accelerated so that the same will become effective on June 25, 2020 at 3:00 p.m. Eastern Time, or as soon thereafter as is practicable.
Very truly yours, | |||
Titan Medical Inc. | |||
By: | /s/ Stephen Randall | ||
Name: Stephen Randall | |||
Title: Chief Financial Officer |
cc: Richard Raymer (Dorsey & Whitney LLP)